News & AnalysisVentyx Biosciences fetches $114mVentyx Biosciences, a biotech company, has raised $114 million in funding.ByIris Dorbian9 March 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs